A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.
Автор: | Haque, Mushfiqul |
---|---|
Інші автори: | Kabir, Md. Tanvir |
Формат: | Project report |
Мова: | English |
Опубліковано: |
BRAC University
2019
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/11070 |
Схожі ресурси
-
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
за авторством: Ishrat, Nowshin
Опубліковано: (2024) -
Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
за авторством: Alam, Badrul, та інші
Опубліковано: (2016) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024) -
A review on artemisinin based combination therapy for the treatment of Malaria
за авторством: Chowdhury, Amina Ferdous
Опубліковано: (2020) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
за авторством: Alim, Abdul
Опубліковано: (2023)